q00-q99. q30/9 -Congenital Malformation of nose ? Unspecitied
Conditions
Interventions
Intervention 1: After being anesthetized patients before surgical incision a group of 30 patients drug Labetalol with dose /4-3 mg/ kg/hr beginning to the end of the operation with a 50 cc syringe i
Treatment - Drugs
After being anesthetized patients before surgical incision a group of 30 patients drug Remifentanil with dose /1-3 mic/kg/min beginning to the end of the operation with a 50cc syringe infusion pump op
After being anesthetized patients before surgical incision a group of 30 patients drug Labetalol with dose /4-3 mg/ kg/hr beginning to the end of the operation with a 50 cc syringe infusion pump ope
Sponsors
Shiraze University of Medical Sciences ?Researh
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion:The patient with ASA 1-2 ;Men or Women between 18- 50 years; Disease without surgery Rhinoplasty;No patient had a history or physical exam of clotting problems; Blood pressure above then 100/70 mm/Hg ;Heart rate above then 40 mint;No history of Obstractive lung disease and Heart disease . Exclusion criteria: Patient with ASA above 2;Men or Women with Age less then 18 years and age above then 50 years; Repeat Rhinoplasty surgery ;Coagulation problem in history and physical exam;Blood pressure less then100/70mm/Hg;Heart rate less then 40 mint;History Obstractive lung disease and any Heart disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of intraoperative bleeding. Timepoint: The end of surgery. Method of measurement: Measurement of blood in the suction.;Evaluate the quality of the surgical site by the Surgen. Timepoint: The end of surgery. Method of measurement: Evaluate with table Boezaart by Surgen. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Artrial Pressure. Timepoint: During the study every 15 minute. Method of measurement: Pressure Set-Blood Pressure Monitoring.;Heart Rate. Timepoint: During the study every 15 minute. Method of measurement: Anesthesia Monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdoreza Gholami
Shiraz Universityof Medical Sciences
Outcome results
None listed